New hope for rare bone cancer: experimental combo shows promise
Disease control
Completed
This study tested a new drug called TK216 combined with vincristine in 15 people with Ewing's sarcoma that had come back or stopped responding to treatment. The goal was to see if the combination could shrink tumors or slow the cancer. The trial was completed in China and focused…
Phase: PHASE2 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated May 17, 2026 08:01 UTC